Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598223 | 1.00 | MME (0.35) | MME | |
| SCHEMBL2958246 | 1.00 | MME (0.35) | MME | |
| SCHEMBL2958250 | 1.00 | MME (0.35) | MME | |
| SCHEMBL9665040 | 1.00 | MME (0.35) | MME | |
| SCHEMBL9665035 | 1.00 | MME (0.35) | MME | |
| Hydrochloric Acid SCHEMBL8732198 | 0.99 | MME (0.34) | MME | |
| Hydrochloric Acid SCHEMBL30575098 | 0.99 | MME (0.34) | MME | |
| Hydrochloric Acid SCHEMBL6933795 | 0.99 | MME (0.34) | MME | |
| SCHEMBL30712894 | 0.97 | SLC15A2 (0.35) | MME | |
| SCHEMBL29891666 | 0.97 | SLC15A2 (0.35) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409517-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-12 | — | — | US | claimed |
| EP-4415561-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-08-21 | — | — | EP | claimed |
| CN-118102889-A | Organic compound | 奇华顿股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2023062110-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2023-04-20 | — | — | WO | claimed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| US-7758771-B2 | Product for transformation of a toxic corrosive or environmentally-noxious liquid product into a non-corrosive or non-noxious residue | Meyer, Marie-Claude (FR) | 2010-07-20 | — | — | US | claimed |
| US-20090224202-A1 | PRODUCT FOR TRANSFORMATION OF A TOXIC CORROSIVE OR ENVIRONMENTALLY-NOXIOUS LIQUID PRODUCT INTO A NON-CORROSIVE OR NON-NOXIOUS RESIDUE | MEYER, MARIE-CLAUDE (FR) | 2009-09-10 | — | — | US | claimed |
| EP-1558368-B1 | METHOD FOR PH-BIASED ISOELECTRIC TRAPPING SEPARATIONS | TEXAS A & M UNIV SYS (US) | 2006-09-27 | — | — | EP | claimed |
| US-20060151325-A1 | Method for ph-biased isoelectric trapping separations | TEXAS A&M UNIVERSITY SYSTEM, THE | 2006-07-13 | — | — | US | claimed |
| CN-1668367-A | Method for pH-shifted isoelectric trapping of educts | TEXAS A & M UNIV SYS (US) | 2005-09-14 | — | — | CN | claimed |
| EP-1558368-A1 | METHOD FOR PH-BIASED ISOELECTRIC TRAPPING SEPARATIONS | The Texas A & M University System (US) | 2005-08-03 | — | — | EP | claimed |
| WO-2003103811-A1 | METHOD FOR PH-BIASED ISOELECTRIC TRAPPING SEPARATIONS | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2003-12-18 | — | — | WO | claimed |
| US-20030226752-A1 | Adjust concentration of sample; electrophoresis gradients | GRADIPORE LIMITED (AU) | 2003-12-11 | — | — | US | claimed |
| US-12331333-B2 | Enhancers of neurolysin activity | TEXAS TECH UNIVERSITY SYSTEM (US) | 2025-06-17 | — | — | US | disclosed |
| US-20240409517-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-12 | — | — | US | disclosed |
| EP-4415561-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| US-5008388-A | For treatment of various types of anemia | HUHTAMAKI OY (FI) | 1991-04-16 | — | — | US | disclosed |
| CN-1043392-A | The composition and the diagnostic method that are used for diagnosing liver cancer | VETERINARIAN UNIV CHINESE P L (CN) | 1990-06-27 | — | — | CN | disclosed |
| EP-0304954-A2 | Cyclic dipeptide enantiomers | ICI AUSTRALIA LIMITED (AU) | 1989-03-01 | — | — | EP | disclosed |
| EP-0132392-A2 | Asymmetric synthesis of alpha-substituted-alpha-cyanomethyl alcohols | ICI AUSTRALIA LIMITED (AU) | 1985-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12331333-B2 | Enhancers of neurolysin activity | GAP43, NLN, BDNF | MME 63/4885 |
| US-20240409517-A1 | ORGANIC COMPOUNDS | HTR3C, HTR3A, H1-0 | MME 4676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.